Clinical Trial Detail

NCT ID NCT02754726
Title Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors HonorHealth Research Institute
Indications

pancreatic ductal adenocarcinoma

Therapies

Cisplatin + Gemcitabine + Nab-paclitaxel + Nivolumab + Paricalcitol

Age Groups: adult

No variant requirements are available.